Multicellular organisms have evolved sophisticated defense systems to confer protection against pathogens. An important characteristic of these immune systems is their ability to act both locally at the site of infection and at distal uninfected locations. Insects rely on multiple immune responses to combat infection; one of them is
RNA interference (RNAi).
Further reading:
Labels: RNA interference, RNAi
Since its discovery in 1998,
RNA interference (RNAi) has heralded the advent of novel tools for biological research and drug discovery. This exciting new technology is emerging as a powerful modality for battling some of the most notoriously challenging viral clinical targets such as hepatitis C virus (HCV) and human immunodeficiency virus (HIV). However, several critical issues associated with this novel technology must be resolved before it can progress to testing in human clinical trials, and these have been the target of intensive research in recent years.
from:
Labels: RNA interference